Nafeh M A, Medhat A, Shehata M, Mikhail N N, Swifee Y, Abdel-Hamid M, Watts S, Fix A D, Strickland G T, Anwar W, Sallam I
Hepatitis C Prevention Project, Faculty of Medicine, Assiut University, Egypt.
Am J Trop Med Hyg. 2000 Nov-Dec;63(5-6):236-41.
The prevalence of antibody to hepatitis C virus (anti-HCV) was determined in a cross-sectional survey in a village in Upper Egypt. Exposure and demographic characteristics were obtained through a questionnaire. Antibody to hepatitis C virus was assessed using a second generation enzyme immunoassay, and the presence of HCV RNA was tested using a reverse transcriptase-polymerase chain reaction. Collection of blood samples was targeted at those > or = 5 years old, and obtained from 62.8%. This report describes the community, the HCV infection characteristics of the subjects, and evaluates some factors associated with presence of anti-HCV. Of the 6,031 participants, 522 (8.7%) were anti-HCV positive. Prevalence was higher among males than females (11.3% versus 6.5%; P < 0.001). It was greater among those > 30 years of age than among those < or = 30 years of age (20.0% versus 3.6%; P < 0.001). Those who were less educated, farmed, provided health care, and were currently married had a significantly higher anti-HCV prevalence than those who were not; however, these associations were not significant after adjusting for age. Although active infections with Schistosoma haematobium were not associated with anti-HCV, a history of past infection was (age-adjusted risk ratio [RR] = 2.1, 95% confidence interval [CI] = 1.8, 2.4); 134 persons who had a history of receiving parenteral anti-schistosomal therapy had a higher age-adjusted RR (3.0; 95% CI = 2.5, 3.7) for anti-HCV than those who did not. Hepatitis C virus RNA was detected in 62.8% of the anti-HCV positive subjects, without significant variation by age, gender, education, or marital status. The prevalence of anti-HCV in Upper Egypt is high, albeit lower than in Lower Egypt, with continuing but limited transmission indicated by the lower prevalence in residents < or = 30 years old.
在埃及上埃及一个村庄开展的横断面调查中,测定了丙型肝炎病毒抗体(抗-HCV)的流行情况。通过问卷调查获取暴露情况和人口统计学特征。使用第二代酶免疫测定法评估丙型肝炎病毒抗体,并使用逆转录聚合酶链反应检测HCV RNA的存在。血液样本采集针对年龄大于或等于5岁的人群,采集率为62.8%。本报告描述了该社区、受试者的HCV感染特征,并评估了一些与抗-HCV存在相关的因素。在6031名参与者中,522人(8.7%)抗-HCV呈阳性。男性的患病率高于女性(11.3%对6.5%;P<0.001)。30岁以上人群的患病率高于30岁及以下人群(20.0%对3.6%;P<0.001)。受教育程度较低、从事农业、提供医疗保健以及目前已婚的人群抗-HCV患病率显著高于未从事这些活动的人群;然而,在调整年龄后,这些关联并不显著。虽然埃及血吸虫的活动性感染与抗-HCV无关,但既往感染史与抗-HCV有关(年龄调整风险比[RR]=2.1,95%置信区间[CI]=1.8,2.4);有接受过肠道外抗血吸虫治疗史的134人抗-HCV的年龄调整RR更高(3.0;95%CI=2.5,3.7)。在62.8%的抗-HCV阳性受试者中检测到HCV RNA,在年龄、性别、教育程度或婚姻状况方面无显著差异。埃及上埃及抗-HCV的患病率较高,尽管低于下埃及,30岁及以下居民较低的患病率表明传播仍在继续,但范围有限。